© 2026 Sinochem Nanjing Corporation,
All Right Reserved
Tolfenamic acid didn’t simply appear on pharmacy shelves overnight. Born out of the vast and storied effort of mid-20th century pharmaceutical research, it found its home among nonsteroidal anti-inflammatory drugs. Developed in the laboratories of Europe, researchers responded to the growing need for alternatives to aspirin and other early NSAIDs, searching for compounds that controlled pain and inflammation but presented fewer gastrointestinal side effects. The introduction of tolfenamic acid opened new treatment options for specific migraine pains and inflammatory disorders. Decades later, its longevity stands as proof of both broad pharmacological curiosity and the stubborn pursuit of better symptom relief during times when headaches or joint pain would otherwise rule a patient’s day.
Tolfenamic acid wears many hats in medicine and veterinary science, standing out as a solid choice against pain and inflammation. Its reliable performance in the form of tablets and injectable solutions serves as a backbone for migraine management in some European and Asian countries. Outside hospitals and clinics, veterinarians have made good use of it for cattle and swine fighting fever and swelling brought on by infections or injuries. In my own experience, it’s filled that gap when ibuprofen or aspirin fell short, providing tangible relief to those who struggle with recurring migraines. Its place on the essential drug lists may be patchy across continents, but to those who count on it, the effects are anything but trivial.
Tolfenamic acid presents itself as a white to almost pale yellow crystalline powder. It carries a molecular weight of 261.27 g/mol and the formula C14H12ClNO2. Solubility leans strongly towards organic solvents like ethanol and acetone, while its interaction with water remains stubbornly limited. Melting point sits at 213–215°C, reflecting its robust structure, which withstands everyday environmental pressures. In labs, an unmistakable faint odor lingers after opening a fresh sample, a subtle reminder of its organic origin. Handling the powder feels a bit tricky owing to its fine texture, regularly escaping the scoop, serving as a quick lesson in patience for every chemist or technician on the job. These small details in the lab make every bottle of tolfenamic acid memorable.
Manufacturers stamp out tolfenamic acid to precise purity levels, consistently targeting not less than 98%. Product labels highlight batch numbers, expiration dates, purity grades, country-specific usage guidelines, and regulatory endorsements, which remain non-negotiable in global distribution. Some packaging even supplies stability information, pointing to proper storage below 25°C and away from light — a detail that prevents waste and keeps medications effective on the shelf. Regulatory authorities require clear warnings for both handlers and end users, mindful of safety around long-term or high-dose exposure. Looking at a freshly labeled bottle shows the traceability necessary to guarantee the medicine’s journey from factory to patient, where users deserve absolute clarity on what’s going into their body.
Producing tolfenamic acid follows an established synthetic route, typically starting with 3-chloroaniline and 2-methylbenzoyl chloride. The reaction, often powered by a base such as pyridine, proceeds through acylation and closes the ring structure, after which purification steps remove byproducts and impurities. Technicians here must pay attention to temperature controls, reaction timing, and solvent choices — any slip risks a compromised final product. Having stood over a flask during these preparations, I learned firsthand that the transformation from raw chemicals to finished acid isn’t just technical, but a genuine test of skill and attention. The crystallization and washing steps, though seemingly routine, decide the purity and consistency every batch needs, from research applications to full-scale pharmaceutical manufacturing.
In the lab, tolfenamic acid provides a straightforward substrate for a range of chemical transformations. Its aromatic rings invite nitration, halogenation, or further acylation. Medicinal chemists often experiment with these modifications, searching for even better anti-inflammatory or analgesic properties. Some analogues already populate patent databases, their creators chasing tweaks in solubility or reduced side effects. Drug metabolism studies indicate glucuronidation and hydroxylation as primary routes in the human body, which has ripple effects downstream in toxicology and pharmacokinetics. Watching these compounds shift through reactivity and metabolism helps scientists fine-tune their profiles, aiming for improvements that might one day shake up the pain management playbook.
Tolfenamic acid appears in listings and pharmacies under a medley of names: Clotam, Tufnil, and generic entries. Chemists may refer to it as 2-[(3-chloro-2-methylphenyl)amino]benzoic acid in the literature, demonstrating its place on the lengthy roster of substituted anthranilic acids, also known as fenamates. Commercial packs rarely display the complex chemical designation, focusing instead on recognizability for patients and prescribers. In veterinary spaces, injectable forms sit under region-specific brand duologies, depending on registration status and distribution networks. This jumble of names can trip up anyone new to pharmaceutical procurement, so double-checking for both scientific and brand identifiers saves no shortage of headaches for pharmacists, veterinarians, and researchers alike.
Strict standards rule every step of tolfenamic acid’s lifecycle. Handling raw powder or concentrated solutions calls for gloves, masks, and protective eyewear, just as caution guides storage and disposal. Occupational health protocols, often laid out by agencies such as OSHA and the European Chemical Agency, address inhalation, skin contact, and accidental ingestion risks. In production, regular audits and pharmacovigilance databases track adverse reactions, providing the backbone for continual improvement. From personal experience in research settings, I’ve seen teams respond quickly to trace contamination or exposure reports by ramping up training and updating standard operating procedures. This vigilance has dramatically reduced worker injury and environmental harm.
Doctors and veterinarians reach for tolfenamic acid mainly because of its established analgesic and anti-inflammatory power. In human medicine, it finds its role treating acute migraine attacks and moderate pain linked to dysmenorrhea or skeletal issues. In farm animals, veterinarians use it to battle fever and inflammation, especially when speed and ease of use matter in large herds. In these environments, tolfenamic acid’s quick action can make the difference between a productive workweek and one hobbled by sick livestock. Away from the front lines of practice, its data has underpinned pharmaceuticals for decades, shaping how pain and fever are controlled in both city clinics and rural outposts.
Investigations into tolfenamic acid continue to push the boundaries. Teams are probing its uses in less-charted conditions, like rare inflammatory disorders and certain cancer pathways. Recent preclinical studies have highlighted its capacity to modulate cyclooxygenase activity, which in turn influences everything from pain to tumor progression. Universities and pharmaceutical companies keep re-examining its safety, searching for interaction risks with newer medications or potential enhancements through novel formulations. By focusing research efforts on bioavailability improvements and adverse event reduction, today’s R&D teams build on the foundation laid decades ago, always looking to bring patients a better experience than their parents or grandparents might have had.
Understanding risk isn’t optional, particularly with drugs like tolfenamic acid. Researchers have catalogued its side effects, which can mirror those of other fenamates: gastrointestinal distress, skin reactions, and rare but serious kidney or liver issues. Careful animal studies laid out the basic safety profile, while post-approval surveillance exposed less common but deeply serious outcomes such as gastrointestinal bleeding or hypersensitivity. In clinical use, monitoring for changes in blood cell counts and kidney function can spot early warning signs. Reflecting back, I’ve seen the impact when prescribers remain vigilant and talk through risks clearly with patients—it’s saved more than one person from ending up in the emergency room. These hard-learned lessons underscore the high stakes every time a script for a powerful NSAID leaves the pharmacy counter.
Tolfenamic acid’s story isn’t closing any time soon. Younger researchers are exploring its broader impact, connecting its chemical structure to possible breakthroughs in brain health, neuroinflammation, and cancer biology. The development of new solid dispersions and nanoformulations aims to broaden its reach, extend shelf life, and ease administration for groups like the elderly or children. Health systems and regulatory watchdogs remain sharply focused on real-world data, updating best practices as new evidence emerges. In the right hands, this legacy molecule offers hope for both forgotten pain sufferers and an entirely new class of therapies beyond its original use. For the next generation, tolfenamic acid could open unexpected corridors in both medicine and chemical science.
Tolfenamic acid lives on pharmacy shelves as a member of the nonsteroidal anti-inflammatory drug (NSAID) family. Most people know NSAIDs for their role in fighting headaches, achy joints, or fevers. Tolfenamic acid typically doesn't end up in household medicine cabinets, but in countries across Europe and Asia, doctors write prescriptions for it, mainly to tackle migraine attacks. Decades of use have built up quite a bit of real-world know-how around this medicine, even if it doesn’t get the same limelight as ibuprofen or aspirin.
Migraine patients can feel desperate when pain and sensation overwhelm their daily lives. These aren’t ordinary headaches—they knock people off their planned routines, affecting work and relationships. Studies show tolfenamic acid helps most migraine sufferers by calming inflammation in blood vessels around the brain. This gives people a fighting chance to reclaim a normal day. In Norway and Finland, for example, doctors have trusted this medicine since the 1980s, leaning on research backing up its effectiveness.
People who struggle with stomach irritation from other NSAIDs sometimes find tolfenamic acid gentler on their system. Migraines don’t always respond well to common painkillers, so offering another option makes a difference for folks who feel let down by standard pills. Doctors also like the flexibility to rotate medicines, lowering the risk of side effects piling up.
Relief from pain isn’t just a human concern. Veterinarians reach for tolfenamic acid, too, using it mainly to treat cattle and pigs. Farmers deal with joint swelling, fever, and infections that slow down animals and cut into their productivity. A shot of tolfenamic acid helps livestock recover faster and improves their overall well-being. Animal welfare laws in many regions support this practice, since reducing pain and discomfort honors our responsibility to treat farm animals humanely.
Like all NSAIDs, tolfenamic acid brings some risks. Too much can lead to stomach problems, kidney strain, or trigger allergic reactions, especially in those who’ve reacted badly to other similar medicines. At the pharmacy, pharmacists give reminders about possible interactions with other prescriptions. Monitoring for side effects matters, and doctors often check in to see how patients’ bodies handle a new prescription.
As someone whose friends live with chronic migraines, I’ve seen the frustration that comes when nothing seems to work. New clinical trials in countries like India and China dig deeper into how tolfenamic acid works in the long run compared to well-known migraine medications. Research also explores its anti-cancer and neuroprotective effects, which opens the door to new uses beyond pain relief. Scientists already see signs that tolfenamic acid changes certain gene activity in cells, which could bring breakthroughs for other diseases down the road.
Access to tolfenamic acid changes lives for people and animals struggling with inflammation. More options at the pharmacy mean a better chance to find the right solution for each case. While education and conversation between patient, doctor, and pharmacist matter most, so does learning from ongoing research. Assessing personal risks and benefits, and knowing that real solutions sometimes call for less familiar names, gives everyone a bit more hope.
Tolfenamic acid usually comes up in conversations for people dealing with tough headaches or certain musculoskeletal pains. As a nonsteroidal anti-inflammatory drug, or NSAID, it works a lot like ibuprofen or naproxen. People use it to chase away pain and get through demanding days. In my circle, some deal with migraines so stubborn nothing else cuts through the haze. For some, tolfenamic acid means less time curled up in a dark room and more time enjoying life. But every pill involves a trade-off.
A friend once described her experience as “worth the relief, but my stomach paid the price.” Like many other NSAIDs, tolfenamic acid likes to poke holes in your good mood by agitating the stomach lining. Nausea, heartburn, and mild indigestion are routine stories. Sometimes these troubles can spiral into worse situations, like ulcers or even stomach bleeding, especially for someone with a history of gastric problems or who relies on painkillers almost every week.
Doctors often say eat something before taking anything in this drug family. Empty stomach plus NSAIDs equals higher risk. Fact is, these side effects get underestimated because they're so common, but they’re serious enough to send folks to the clinic if ignored. If someone notices tarry stools or vomits blood, that signals a problem that can't wait for a routine appointment.
Pain-free days sometimes distract from what these medications can do to other parts of the body. Tolfenamic acid, like its cousins, puts extra strain on kidneys. I remember an older neighbor who started showing signs of swelling and new blood pressure problems. He used NSAIDs almost daily for arthritis. Blood tests showed his kidney numbers weren't where they should be. Even people without a long history of kidney trouble see changes, especially if they take higher doses or combine the drug with other medicines.
The cardiovascular risks get a lot less attention but they matter. Studies link frequent NSAID use with higher numbers of heart attacks and strokes. For folks with existing heart issues or those in their senior years, it’s worth talking over the risks with a doctor. Short-term use may feel safe, but add in other risk factors—like smoking or diabetes—and the equation shifts fast.
Serious allergic responses happen sometimes. Someone might break out in rashes, start itching, or their face swells up. More dangerous reactions can block airways or make it hard to breathe. These sound extreme but they happen quickly and demand a ride to the ER, not just resting at home.
Liver issues stay in the background, but they’re possible. Dark urine, yellow skin, or pain in the upper right tummy can signal a bigger problem. Anyone who adds alcohol or other medications processed by the liver needs to stay vigilant and communicate with their physician.
Trust plays a huge role in how people use painkillers. Some see the pharmacy shelf and feel safe trying something new, but even a familiar medicine deserves respect. Reading the drug sheet, asking questions during check-ups, and sharing all prescriptions with a healthcare team helps avoid stacking risks. For chronic pain, talking about other options—like physical therapy, mind-body approaches, or non-drug treatments—can reduce the workload on the stomach and heart.
Tolfenamic acid does its job well, but anyone using it should look out for telltale symptoms and set honest boundaries with their doctor. Staying alert to how the body responds each time offers better odds of relief without lasting harm.
Real life seldom goes as neatly as the directions on a bottle. People deal with headaches, fevers, pain, and chronic inflammation more than they like to admit. For many, Tolfenamic Acid sits on pharmacy shelves as another label in the vast aisle of pain relief. Still, using it safely is no casual task. Doctors, pharmacists, and researchers have spent years figuring out how to help people get real relief without the regret of unwanted side effects. I’ve watched friends grapple with gut issues because they skipped meals before popping their prescription. That’s a familiar mistake, but it’s one that sticks because of pain that follows. Taking Tolfenamic Acid comes down to a mix of knowledge, habit, and respect for your own well-being.
No two bodies process medicine exactly the same way. Age, body weight, kidney function, even what you ate that day—everything plays a role. Doctors consider all of these factors. They look at the bigger picture and decide on a dose and timing that fits your story. It makes a difference if you’re dealing with migraine, severe arthritis, or post-surgical pain. Strong painkillers come with risks, and this medicine can upset your stomach or mess with your liver if you don't follow the directions. In fact, the World Health Organization has also set dosing ranges to balance between comfort and safety. Always speak up about what other pills you take, or any issues with your liver, stomach, or allergies. Open conversation with your doctor can save a lot of grief later.
Most folks receive Tolfenamic Acid as tablets. Swallowing it with water after a meal stops a lot of stomach mischief before it starts. A light breakfast or small snack is enough to give your gut a buffer. Still, swallowing an extra couple glasses of water helps keep your system moving smoothly, limiting chances of heartburn or acid pain. Some clinics give it by injection, especially if someone’s too sick to take pills or needs instant relief. This route always happens in a clinic setting.
If you use other medications—especially blood thinners, steroids, or water pills—bring it up every time you see your doctor or pharmacist. That conversation isn’t just routine; they recognize patterns people don’t catch on their own. Combining different medicines can set off new problems, from kidney concerns to bleeding issues.
It’s easy to focus only on pain, but side effects sneak up if you let your guard down. Signs like unexplained tiredness, yellowing skin, trouble breathing, or severe stomach pain mean stop and call for help right away. Minor stuff like heartburn or constipation shows up more often, but telling your provider early can prevent small problems from turning into big ones. This medicine doesn’t belong to the same group as over-the-counter painkillers. Higher strength means higher stakes, so respect the instructions and keep a list of your medications handy for every appointment.
Routine may sound boring, but it helps you avoid trouble. Take medicine at the same time each day, keep your water intake steady, and schedule check-ins with your care team. Skipping doses or guessing on timing usually ends badly. Pill organizers, reminders on your phone, or printed schedules offer simple tricks to keep yourself on track. Share any changes in symptoms or new aches so your care team can adjust your plan if needed.
Pain can take over daily life, and plenty of folks dealing with migraines or arthritis have tried all kinds of meds. Tolfenamic acid landed in my radar years ago thanks to a family member’s struggle with severe headaches. It delivered quick comfort. But over time, we started noticing people trade one problem for another—relief comes at a price when a drug is used for months or years.
Doctors have leaned on tolfenamic acid, a nonsteroidal anti-inflammatory drug (NSAID), to knock back swelling and pain. Clinical studies chart its usefulness for migraines and joint pain. The trouble is, much of the safety data only follows folks for weeks—sometimes a couple months. There’s a gap in long-term studies, especially for people with other health issues. The initial research shows typical NSAID risks: upset stomach, burning sensation, even ulcers, and higher blood pressure. If you have asthma or kidney problems, doctors get extra cautious.
Stories from real life stick with me far more than dry numbers. I worked with someone whose aches didn’t quit after an ankle injury. After a stretch of tolfenamic acid, her stomach started rebelling. She thought it was just bad luck—and only found out the link after switching doctors. It’s a common tale. Many people don’t match gut trouble with a pain pill until things get serious.
Tolfenamic acid works—sometimes quickly, knocking severe pain down so folks can get back to living. But it lines up with NSAIDs like ibuprofen and naproxen in terms of risk. The gut feels the squeeze first. If you’ve ever had acid reflux or an ulcer, using it for a year or more stacks the odds of hospital visits and more pills to fix what the first ones broke. The kidneys don’t handle long-term pressure from NSAIDs well, especially for older adults and those with heart problems.
I’ve watched friends rotate from one anti-inflammatory to another. At some point, they end up back at the doctor with questions about their blood pressure or ringing in their ears. Chronic use opens the door for problems most people never think about, like kidney function slowly sliding off course or hidden bleeding in the gut.
Nobody wants a life defined by pain, but trading pain for new health worries isn’t a solution either. People dealing with headaches or chronic aches should keep doctors in the loop if painkillers become a regular thing. Regular checkups, blood tests, and talking about even minor symptoms like stomach pain or dark stools can flag early signs of trouble.
Alternatives exist, though some require patience and teamwork with doctors—things like switching up meds, trying physical therapy, focusing on weight, or tackling inflammation through diet. Not every case allows this path, but too many folks settle for short-term peace without thinking about next year or the year after.
Good health is a balancing act. Tolfenamic acid promises an easier ride today, but long-term safety should always guide the path forward. If you or someone close uses it often, staying alert and having honest discussions with healthcare professionals can deliver more lasting comfort.
Tolfenamic acid, a non-steroidal anti-inflammatory drug (NSAID), plays a role in treating pain and inflammation. In my medical experience, animal clinics stocked it to manage conditions like arthritis and post-surgery aches in dogs and cats. In Europe and some parts of Asia, vets have relied on it to get sick pets back on their feet faster. But let’s not skip a basic truth: not every medicine that’s safe for adults or one species works out the same in kids or all kinds of animals.
Children’s bodies aren’t just smaller—they process medicines in their own way. Tolfenamic acid comes with known risks for the stomach, kidneys, and sometimes even the brain. In people under 18, data remains pretty slim and mostly dated. The few studies out there don’t give parents or doctors much comfort. A few years ago, I checked hospital records for kids who’d taken NSAIDs improperly. We saw ulcers in stomachs and unexplained headaches. Those are real red flags. For pediatric pain relief, doctors lean on ibuprofen or acetaminophen instead. Their safety records have seen deep studies over decades, so risks are well mapped out.
Dogs and cats sometimes need something for pain, and animals handle most NSAIDs differently from humans. Vets in some countries prescribe tolfenamic acid for joint or dental pain, but even here, the margin for error is tight. Like many vets, I learned to worry about kidney and liver health both before and after handing out an NSAID—especially in older pets or breeds known for sensitivities. The Royal Veterinary College in the UK lists tolfenamic acid as an option, but only under a vet's close watch. Long-term use brings up issues like vomiting, diarrhea, and—less visible but more dangerous—damage to internal organs.
It’s tempting to assume that if a drug works for one group, everyone else should be fine. In reality, gaps in research leave plenty of gray. For tolfenamic acid in kids and pets, big, high-quality studies just aren’t there. Regulatory agencies like the FDA haven’t cleared it for children. The European Medicines Agency set rules on animal use, calling for careful dose calculations and routine blood tests. These moves reflect caution, not comfort with routine use.
There's a better approach than guessing or borrowing from adult medicine cabinets. For children, rely on treatments doctors know well and are approved for their age. If pain lingers, ask a pediatrician about what’s safe. For pets, a responsible vet should always be involved. Lab work before and during treatment can catch trouble before it spirals. Sticking with trusted NSAIDs like carprofen or meloxicam makes sense for most cats and dogs. Farmers looking to treat livestock need to follow strict dosing rules and observe meat or milk withdrawal periods to keep food supplies safe.
Taking shortcuts with pain relievers can backfire—especially for the youngest and most vulnerable patients. I’ve seen more worry than relief in families and pet owners who thought an over-the-counter fix would work in a pinch. Medical and veterinary care should always focus on weighing benefits and risks, using the safest tool for the job.
| Names | |
| Preferred IUPAC name | N-(2-methyl-3-chlorophenyl)anthranilic acid |
| Other names |
Clotam Tolfedine TA Nofen Tolfen |
| Pronunciation | /ˌtɒl.fəˈnæm.ɪk ˈæs.ɪd/ |
| Identifiers | |
| CAS Number | 13710-19-5 |
| 3D model (JSmol) | `5 1 C1(CC(=CC(=O)O)C2=CC=CC=C2N1)C3=CC=CC=C3` |
| Beilstein Reference | 1206651 |
| ChEBI | CHEBI:32211 |
| ChEMBL | CHEMBL1437 |
| ChemSpider | 2046 |
| DrugBank | DB11374 |
| ECHA InfoCard | 03cf0732-ec63-4e7f-817d-8b1d8aebbbc1 |
| EC Number | 607-533-4 |
| Gmelin Reference | 613486 |
| KEGG | C14158 |
| MeSH | D014069 |
| PubChem CID | 6918054 |
| RTECS number | XR1925000 |
| UNII | 8L5Z9U71EE |
| UN number | UN3077 |
| Properties | |
| Chemical formula | C14H12ClNO2 |
| Molar mass | 261.27 g/mol |
| Appearance | White or almost white crystalline powder |
| Odor | Odorless |
| Density | 1.37 g/cm³ |
| Solubility in water | Slightly soluble in water |
| log P | 2.7 |
| Vapor pressure | 1.7E-10 mmHg at 25°C |
| Acidity (pKa) | 4.4 |
| Basicity (pKb) | 13.81 |
| Magnetic susceptibility (χ) | -66.2e-6 cm³/mol |
| Refractive index (nD) | 1.665 |
| Dipole moment | 2.69 D |
| Thermochemistry | |
| Std molar entropy (S⦵298) | 262.6 J·mol⁻¹·K⁻¹ |
| Std enthalpy of formation (ΔfH⦵298) | -251.8 kJ/mol |
| Std enthalpy of combustion (ΔcH⦵298) | -6426 kJ/mol |
| Pharmacology | |
| ATC code | M01AG02 |
| Hazards | |
| Main hazards | Harmful if swallowed, causes serious eye irritation, may cause respiratory irritation. |
| GHS labelling | GHS07, GHS08 |
| Pictograms | GHS05, GHS07 |
| Signal word | Warning |
| Hazard statements | H302, H315, H319, H335 |
| Precautionary statements | P264, P270, P273, P301+P312, P305+P351+P338, P330, P501 |
| Flash point | 120.8°C |
| Autoignition temperature | 400 °C |
| Lethal dose or concentration | LD₅₀ (oral, rat): 400 mg/kg |
| LD50 (median dose) | 330 mg/kg (oral, rat) |
| NIOSH | MF9279000 |
| PEL (Permissible) | Not established |
| REL (Recommended) | 200 mg |
| Related compounds | |
| Related compounds |
Mefenamic acid Flufenamic acid Meclofenamic acid Diclofenac Niflumic acid |
